ALGS Financials
Aligos Therapeutics Inc - Financial statements & key metrics
Stock Price
$7.21
Market Cap
$44.09M
P/E Ratio
-0.3
EPS
$-13.54
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$3.61M
Gross Profit
-
Operating Income
-
Net Income
$-131.21M
EPS (Diluted)
$-20.94
Balance Sheet Highlights
Total Assets
$70.09M
Total Liabilities
$99.07M
Shareholders Equity
-
Cash & Equivalents
$37.00M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-80.74M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-3827.4%
ROE
-141.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ALGS revenue?
ALGS's most recent quarterly revenue was $3.61M. Annual revenue can be calculated by summing the four most recent quarters.
Is ALGS profitable?
ALGS reported a loss of $131.21M in the most recent quarter.
What is ALGS market cap?
ALGS has a market capitalization of $44.09M, making it a small-cap stock.
Does ALGS have debt?
View ALGS's balance sheet for debt information.
What is ALGS cash flow?
Cash flow data is available in the full financial statements.